These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16951377)

  • 1. Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects.
    Kim B; Suvas S; Sarangi PP; Lee S; Reisfeld RA; Rouse BT
    J Immunol; 2006 Sep; 177(6):4122-31. PubMed ID: 16951377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects.
    Kim B; Lee S; Suvas S; Rouse BT
    J Immunol; 2005 Jul; 175(1):509-16. PubMed ID: 15972686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.
    Banerjee K; Biswas PS; Kim B; Lee S; Rouse BT
    J Immunol; 2004 Jan; 172(2):1237-45. PubMed ID: 14707102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology.
    Sharma S; Mulik S; Kumar N; Suryawanshi A; Rouse BT
    J Virol; 2011 Jun; 85(12):5995-6007. PubMed ID: 21471229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
    Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of herpes simplex virus-1 gD or gD-IL-2 DNA vaccine on herpetic keratitis.
    Inoue T; Inoue Y; Hayashi K; Shimomura Y; Fujisawa Y; Aono A; Tano Y
    Cornea; 2002 Oct; 21(7 Suppl):S79-85. PubMed ID: 12484704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation.
    Kim B; Sarangi PP; Lee Y; Deshpande Kaistha S; Lee S; Rouse BT
    J Leukoc Biol; 2006 Dec; 80(6):1405-15. PubMed ID: 16997857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis.
    Biswas PS; Banerjee K; Kim B; Rouse BT
    J Immunol; 2004 Mar; 172(6):3736-44. PubMed ID: 15004178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of immunization with herpes simplex virus glycoprotein D fused with interleukin-2 against murine herpetic keratitis.
    Inoue T; Inoue Y; Nakamura T; Yoshida A; Inoue Y; Tano Y; Shimomura Y; Fujisawa Y; Aono A; Hayashi K
    Jpn J Ophthalmol; 2002; 46(4):370-76. PubMed ID: 12225814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis.
    Zheng M; Deshpande S; Lee S; Ferrara N; Rouse BT
    J Virol; 2001 Oct; 75(20):9828-35. PubMed ID: 11559816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2.
    Erdag B; Balcioglu BK; Bahadir AO; Serhatli M; Kacar O; Bahar A; Seker UO; Akgun E; Ozkan A; Kilic T; Tamerler C; Baysal K
    Biotechnol Appl Biochem; 2011; 58(6):412-22. PubMed ID: 22172104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus.
    Mulik S; Xu J; Reddy PB; Rajasagi NK; Gimenez F; Sharma S; Lu PY; Rouse BT
    Am J Pathol; 2012 Aug; 181(2):525-34. PubMed ID: 22659469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1.
    Rajasagi NK; Reddy PB; Suryawanshi A; Mulik S; Gjorstrup P; Rouse BT
    J Immunol; 2011 Feb; 186(3):1735-46. PubMed ID: 21187448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intramuscular Vaccination With the HSV-1(VC2) Live-Attenuated Vaccine Strain Confers Protection Against Viral Ocular Immunopathogenesis Associated With γδT Cell Intracorneal Infiltration.
    Nabi R; Lewin AC; Collantes TM; Chouljenko VN; Kousoulas KG
    Front Immunol; 2021; 12():789454. PubMed ID: 34868077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robo 4 Counteracts Angiogenesis in Herpetic Stromal Keratitis.
    Gimenez F; Mulik S; Veiga-Parga T; Bhela S; Rouse BT
    PLoS One; 2015; 10(12):e0141925. PubMed ID: 26720197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical administration of HSV gD-IL-2 DNA is highly protective against murine herpetic stromal keratitis.
    Inoue T; Inoue Y; Hayashi K; Yoshida A; Nishida K; Shimomura Y; Fujisawa Y; Aono A; Tano Y
    Cornea; 2002 Jan; 21(1):106-10. PubMed ID: 11805518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anti-vascular endothelial growth factor receptor 2/fetal liver kinase-1 Listeria monocytogenes anti-angiogenesis cancer vaccine for the treatment of primary and metastatic Her-2/neu+ breast tumors in a mouse model.
    Seavey MM; Maciag PC; Al-Rawi N; Sewell D; Paterson Y
    J Immunol; 2009 May; 182(9):5537-46. PubMed ID: 19380802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antimetastatic effect of fetal liver kinase 1 extracellular domain and interferon-gamma fusion gene-modified dendritic cell vaccination.
    Pan J; Heiser A; Marget M; Steinmann J; Kabelitz D
    Gene Ther; 2005 May; 12(9):742-50. PubMed ID: 15729371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.